StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Guided Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $650.00K, up 450.8% year over year. For fiscal 2025 it was $767.00K, up 10857.1% from the year before. Over ten years it grew 33.7% a year on average. The highest annual figure on record is $3.60M in fiscal 2011.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$767.00K+10857.1%
FY2024Dec 31, 2024$7.00K-92.9%
FY2023Dec 31, 2023$98.00K+653.8%
FY2022Dec 31, 2022$13.00K-84.0%
FY2021Dec 31, 2021$81.00K-20.6%
FY2020Dec 31, 2020$102.00K+183.3%
FY2019Dec 31, 2019$36.00K-36.8%
FY2018Dec 31, 2018$57.00K-76.6%
FY2017Dec 31, 2017$244.00K–
FY2016Dec 31, 2016$0-100.0%
FY2015Dec 31, 2015$42.00K-35.4%
FY2014Dec 31, 2014$65.00K-92.1%
FY2013Dec 31, 2013$820.00K-75.4%
FY2012Dec 31, 2012$3.34M-7.2%
FY2011Dec 31, 2011$3.60M+6.9%
FY2010Dec 31, 2010$3.36M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$590.00K+58900.0%
Q3 FY2025Sep 30, 2025$60.00K–
Q2 FY2025Jun 30, 2025$117.00K–
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$1.00K-96.9%
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$6.00K-72.7%
Q4 FY2023Dec 31, 2023$32.00K–
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$44.00K+780.0%
Q1 FY2023Mar 31, 2023$22.00K+340.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$3.00K-84.2%
Q2 FY2022Jun 30, 2022$5.00K+150.0%
Q1 FY2022Mar 31, 2022$5.00K–
Q4 FY2021Dec 31, 2021$60.00K+140.0%
Q3 FY2021Sep 30, 2021$19.00K-75.3%
Q2 FY2021Jun 30, 2021$2.00K–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$25.00K+56.3%
Q3 FY2020Sep 30, 2020$77.00K+7600.0%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$16.00K-61.9%
Q3 FY2019Sep 30, 2019$1.00K-50.0%
Q2 FY2019Jun 30, 2019$1.00K-87.5%
Q1 FY2019Mar 31, 2019$18.00K+350.0%
Q4 FY2018Dec 31, 2018$42.00K-60.7%
Q3 FY2018Sep 30, 2018$2.00K-93.9%
Q2 FY2018Jun 30, 2018$8.00K-90.8%
Q1 FY2018Mar 31, 2018$4.00K-81.0%
Q4 FY2017Dec 31, 2017$107.00K+12.6%
Q3 FY2017Sep 30, 2017$33.00K–
Q2 FY2017Jun 30, 2017$87.00K–
Q1 FY2017Mar 31, 2017$21.00K–
Q3 FY2016Sep 30, 2016$95.00K–

More Guided Therapeutics figures

See a number that looks wrong?